Inspiremd Stock Today
| NSPR Stock | USD 2.72 0.04 1.49% |
Performance4 of 100
| Odds Of DistressLess than 8
|
InspireMD is selling at 2.72 as of the 18th of January 2025; that is 1.49 percent increase since the beginning of the trading day. The stock's lowest day price was 2.66. InspireMD has only a 8 % chance of going through financial distress over the next few years but had a somewhat insignificant performance during the last 90 days. The performance scores are derived for the period starting the 20th of October 2024 and ending today, the 18th of January 2025. Click here to learn more.
Business Domain Health Care Equipment & Services | IPO Date 12th of April 2011 | Category Healthcare | Classification Health Care |
InspireMD, Inc., a medical device company, focuses on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of vascular and coronary diseases in Europe, Latin America, the Middle East, and Asia Pacific. The company has 26.08 M outstanding shares of which 170.72 K shares are now shorted by private and institutional investors with about 5.8 trading days to cover. More on InspireMD
Moving together with InspireMD Stock
Moving against InspireMD Stock
Follow Valuation Options Odds of Bankruptcy
Check how we calculate scores
InspireMD Stock Highlights
ESG Sustainability
Environmental | Governance | Social |
| CEO President | Marvin Slosman | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Thematic Idea | Medical Equipment (View all Themes) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Health Care Equipment & Supplies, Health Care Equipment & Services, Health Care, NASDAQ Composite, NASDAQ Health Care, Medical Equipment, Health Care, Health Care Equipment & Supplies, Medical Devices, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt LevelsInspireMD can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand InspireMD's financial leverage. It provides some insight into what part of InspireMD's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
InspireMD (NSPR) is traded on NASDAQ Exchange in USA. It is located in 4 Menorat Hamaor Street, Tel Aviv, Israel, 6744832 and employs 65 people. InspireMD is listed under Health Care Equipment & Supplies category by Fama And French industry classification. The company currently falls under 'Micro-Cap' category with a current market capitalization of 69.9 M. InspireMD conducts business under Health Care Equipment & Supplies sector and is part of Health Care industry. The entity has 26.08 M outstanding shares of which 170.72 K shares are now shorted by private and institutional investors with about 5.8 trading days to cover.
InspireMD currently holds about 26.47 M in cash with (16.38 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.18, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check InspireMD Probability Of Bankruptcy
Ownership AllocationInspireMD has a total of 26.08 Million outstanding shares. InspireMD secures significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check InspireMD Ownership Details
InspireMD Stock Institutional Holders
| Instituion | Recorded On | Shares | |
| Elias Asset Management Inc | 2024-09-30 | 30 K | |
| Mesirow Fin Investmt Mgmt Intl Equity | 2024-09-30 | 30 K | |
| Northern Trust Corp | 2024-09-30 | 23.6 K | |
| Hollencrest Securities, Llc | 2024-09-30 | 20 K | |
| Geode Capital Management, Llc | 2024-09-30 | 18.2 K | |
| Avestar Capital, Llc | 2024-09-30 | 15 K | |
| Schonfeld Strategic Advisors Llc | 2024-09-30 | 11.9 K | |
| Mckinley Carter Wealth Services Inc | 2024-09-30 | 10 K | |
| Advisornet Financial, Inc | 2024-09-30 | 8.8 K | |
| Rosalind Advisors, Inc. | 2024-09-30 | 2.5 M | |
| Nantahala Capital Management, Llc | 2024-09-30 | 2.2 M |
InspireMD Historical Income Statement
InspireMD Stock Against Markets
InspireMD Corporate Management
| Shane Gleason | Chief Officer | Profile | |
| Roei Samuri | VP Operations | Profile | |
| DVM MD | Executive Affairs | Profile | |
| Andrea Tommasoli | Chief Officer | Profile | |
| Amir Kohen | Vice Resources | Profile |
Additional Tools for InspireMD Stock Analysis
When running InspireMD's price analysis, check to measure InspireMD's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy InspireMD is operating at the current time. Most of InspireMD's value examination focuses on studying past and present price action to predict the probability of InspireMD's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move InspireMD's price. Additionally, you may evaluate how the addition of InspireMD to your portfolios can decrease your overall portfolio volatility.